Agilent Technologies, Inc.

first quarter of fiscal year 2024. With me are Mike McMullen, Agilent President and CEO, Poreg McDonald, Agilent Chief Operating Officer and CEO-elect, and Bob McMahon, Agilent Senior Vice President and CFO and Acting President of the Diagnostics and Genomics Group. Joining in the Q&A will be Phil Binns, President of the Agilent Life Science and Applied Markets Group, and Angelica Reinman, a newly named President of the Agilent CrossLab Group. This presentation is being webcast live. The news release for our first quarter financial results, investor presentation, and information to supplement today's discussion, along with a recording of this webcast, are available on our website at www.investor.agilent.com. Today's comments will refer to non-GAAP financial measures. You will find the most directly comparable GAAP financial metrics and reconciliations on our website. Unless otherwise noted, all references to increases or decreases in financial metrics are year-over-year and references to revenue growth are on a core basis. Core revenue growth excludes the impact of currency and any acquisitions and divestitures completed within the past 12 months. Guidance is based on forecasted exchange rates. As previously announced, beginning in the first quarter of fiscal 2024, We implemented certain changes to our segment reporting structure related to the move of our cell analysis business from LSAG into DGG. We have recast our historical segment information to reflect these changes. These changes have no impact on our company's consolidated financial statements. During this call, we will also make forward-looking statements about the financial performance of the company. These statements are subject to risk and uncertainties and are only valid as of today. The company assumes no obligation to update them. Please look at the company's recent SEC filings for a more complete picture of our risk and other factors. And now, I'd like to turn the call over to Mike.

Thanks Parmeet, and thanks everyone for joining our call. Before I review our first quarter results, I want to first acknowledge our news last week that I'll be retiring at the end of the fiscal year. and that Poreg McDonald is Agilent's new Chief Operating Officer and will become CEO on May 1st. It was a difficult decision to retire. After almost 40 great years with this special company and in a role that I love, I will miss working with the one Agilent team. However, I must say it's a great feeling and quite gratifying to be handing over the CEO reins to a tremendously capable successor in Poreg. With Agilent operating from a position of strength, and with a very promising long-term outlook. I've known Porter for more than 20 years and worked closely with him during that time. He has always been completely committed to our customers and agile success. He is a product of our culture, knows our company, team, and markets, and knows how to develop compelling business strategies, build winning teams, and deliver exceptional results. Porig has a strong track record of results at every position he has held during his 26-year career at Agilent. I know he has the knowledge, leadership skills, and customer focus that will be key to Agilent's success moving forward. I look forward to all of you seeing firsthand what a capable, results-driven leader we have in Porig. Porig, would you like to say a few words?

Thank you, Mike. I'm honored to be able to follow you as Agilent's next CEO. And I'm grateful for your support throughout my career and during this transition. You have made a significant impact on Agilent, our customers, and our team. I'd also like to welcome Angelica Ryman to this call. After leading our services division for the last two and a half years, I can tell you she has the experience and the skill set to continue evolving ACG to align with the growing opportunities that the business has demonstrated in supporting the broad install base and our enterprise customers. Expect to see continued great things ahead from Angelica and ACG. I've had the pleasure of meeting some of you on this call, and I look forward to meeting and working with you all in the future. Agilent has a compelling story to tell, and I'm excited by the possibilities that lie in front of us as we help our customers bring great science to life.